China Universal Asset Management Company’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
18,908
+136
| +0.7% | +$7.52K | 0.1% | 160 |
|
|
2025
Q1 | $908K | Buy |
18,772
+6,135
| +49% | +$297K | 0.08% | 199 |
|
|
2024
Q4 | $488K | Buy |
12,637
+1,308
| +12% | +$50.5K | 0.05% | 253 |
|
|
2024
Q3 | $510K | Buy |
11,329
+4,438
| +64% | +$200K | 0.06% | 214 |
|
|
2024
Q2 | $239K | Sell |
6,891
-4,301
| -38% | -$149K | 0.03% | 215 |
|
|
2024
Q1 | $324K | Buy |
11,192
+4,517
| +68% | +$131K | 0.04% | 232 |
|
|
2023
Q4 | $153K | Buy |
6,675
+5,202
| +353% | +$119K | 0.03% | 234 |
|
|
2023
Q3 | $24.6K | Buy |
1,473
+723
| +96% | +$12.1K | 0.01% | 287 |
|
|
2023
Q2 | $20.7K | Buy |
750
+83
| +12% | +$2.29K | 0.01% | 265 |
|
|
2023
Q1 | $15.3K | Buy |
667
+167
| +33% | +$3.84K | 0.01% | 247 |
|
|
2022
Q4 | $5.46K | Buy |
500
+40
| +9% | +$436 | ﹤0.01% | 288 |
|
|
2022
Q3 | $4K | Buy |
+460
| New | +$4K | ﹤0.01% | 308 |
|